Comprehensive study of the interplay between immunological and metabolic factors in hepatic steatosis

被引:8
作者
Banerjee, Arnab [1 ]
Das, Debasmita [1 ]
Mukherjee, Sandip [1 ]
Maji, Bithin Kumar [1 ]
机构
[1] Serampore Coll, Dept Physiol UG & PG, 9 William Carey Rd, Hooghly 712201, West Bengal, India
关键词
Hepatic steatosis; NAFLD; NASH; HCC; Immune cell regulation; Liver transplantation; FATTY LIVER-DISEASE; NATURAL-KILLER; NKT CELLS; TRANSPLANTATION; INFLAMMATION; SURVIVAL; MOUSE;
D O I
10.1016/j.intimp.2024.112091
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The pathophysiology of hepatic steatosis is thoroughly reviewed in this comprehensive report, with particular attention to the complex interactions between inflammatory pathways, insulin resistance, lipid metabolism, metabolic dysregulation, and immunological responses in the liver including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and hepatocellular carcinoma (HCC). The study highlights the role of immune cell regulation in disease progression and explores the potential of immune cell-specific treatments for treating hepatic disorders. The development of liver disorders is significantly influenced by immune cells, including dendritic cells, T cells, and natural killer cells. Clinical investigations show that immune cellspecific treatments can effectively reduce liver fibrosis and inflammation. Future research should focus on finding new immunological targets for therapeutic interventions, as well as addressing the management challenges associated with NAFLD/NASH. Hepatic immune microorganisms also impact liver homeostasis and disorders. Improvements in immune cell regulation and liver transplantation methods give patients hope for better prognoses. Important phases include optimizing the selection of donors for malignancy of the liver, using machine perfusion for organ preservation, and fine-tuning immunosuppressive strategies. For focused treatments in hepatic steatosis, it is imperative to understand the intricate interactions between immune and metabolic variables. Understanding the liver's heterogeneous immune profile, encompassing a range of immune cell subpopulations, is crucial for formulating focused therapeutic interventions. To improve patient care and outcomes in hepatic illnesses, there is an urgent need for further research and innovation. Therefore, to effectively treat hepatic steatosis, it is important to enhance therapeutic techniques and maximize liver transplantation strategies.
引用
收藏
页数:12
相关论文
共 70 条
[1]   Liver type 1 innate lymphoid cells develop locally via an interferon-γ-dependent loop [J].
Bai, Lu ;
Vienne, Margaux ;
Tang, Ling ;
Kerdiles, Yann ;
Etiennot, Marion ;
Escaliere, Bertrand ;
Galluso, Justine ;
Wei, Haiming ;
Sun, Rui ;
Vivier, Eric ;
Peng, Hui ;
Tian, Zhigang .
SCIENCE, 2021, 371 (6536) :1332-+
[2]   Coccinia grandis alleviates flavor-enhancing high-lipid diet induced hepatocellular inflammation and apoptosis [J].
Banerjee, Arnab ;
Mukherjee, Sandip ;
Maji, Bithin Kumar .
JOURNAL OF FOOD BIOCHEMISTRY, 2022, 46 (05)
[3]   Worldwide flavor enhancer monosodium glutamate combined with high lipid diet provokes metabolic alterations and systemic anomalies: An overview [J].
Banerjee, Arnab ;
Mukherjee, Sandip ;
Maji, Bithin Kumar .
TOXICOLOGY REPORTS, 2021, 8 :938-961
[4]   Mechanistic study of attenuation of monosodium glutamate mixed high lipid diet induced systemic damage in rats by Coccinia grandis [J].
Banerjee, Arnab ;
Das, Debasmita ;
Paul, Rajarshi ;
Roy, Sandipan ;
Das, Ujjal ;
Saha, Samrat ;
Dey, Sanjit ;
Adhikary, Arghya ;
Mukherjee, Sandip ;
Maji, Bithin Kumar .
SCIENTIFIC REPORTS, 2020, 10 (01)
[5]   Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade [J].
Bozward, Amber G. ;
Warricker, Frazer ;
Oo, Ye H. ;
Khakoo, Salim, I .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[6]   Natural Killer-Dendritic Cell Interactions in Liver Cancer: Implications for Immunotherapy [J].
Cazzetta, Valentina ;
Franzese, Sara ;
Carenza, Claudia ;
Della Bella, Silvia ;
Mikulak, Joanna ;
Mavilio, Domenico .
CANCERS, 2021, 13 (09)
[7]   International Liver Transplantation Society Consensus Statement on Immunosuppression in Liver Transplant Recipients [J].
Charlton, Michael ;
Levitsky, Josh ;
Aqel, Bashar ;
O'Grady, John ;
Hemibach, Julie ;
Rinella, Mary ;
Fung, John ;
Ghabril, Marwan ;
Thomason, Ray ;
Burra, Patrizia ;
Little, Ester Coelho ;
Berenguer, Marina ;
Shaked, Abraham ;
Trotter, James ;
Roberts, John ;
Rodriguez-Davalos, Manuel ;
Rela, Mohamed ;
Pomfret, Elizabeth ;
Heyrend, Caroline ;
Gallegos-Orozco, Juan ;
Saliba, Faouzi .
TRANSPLANTATION, 2018, 102 (05) :727-743
[8]   Current Barriers to Clinical Liver Xenotransplantation [J].
Cross-Najafi, Arthur A. ;
Lopez, Kevin ;
Isidan, Abdulkadir ;
Park, Yujin ;
Zhang, Wenjun ;
Li, Ping ;
Yilmaz, Sezai ;
Akbulut, Sami ;
Ekser, Burcin .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[9]   Quercetin inhibits NF-kB and JAK/STAT signaling via modulating TLR in thymocytes and splenocytes during MSG-induced immunotoxicity: an in vitro approach [J].
Das, Debasmita ;
Banerjee, Arnab ;
Mukherjee, Sandip ;
Maji, Bithin Kumar .
MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
[10]   Quercetin counteracts monosodium glutamate to mitigate immunosuppression in the thymus and spleen via redox-guided cellular signaling [J].
Das, Debasmita ;
Banerjee, Arnab ;
Manna, Krishnendu ;
Sarkar, Deotima ;
Shil, Aparna ;
Sikdar , Mausumi ;
Mukherjee, Sandip ;
Maji, Bithin Kumar .
PHYTOMEDICINE, 2024, 126